
Keywords: GBM; Glioblastoma multiforme; CARs; chimeric antigen receptors; PDL1; programmed death ligand 1; IDH1; isocitrate dehydrogenase 1; PMN; polymorphonuclear; TAMs; tumor associated macrophages; HLA; human leucocyte antigen; FLT3L; Fms-like tyrosine kinase 3